Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Nonhuman primate models of Alzheimer-like cerebral proteopathy.

Heuer E, Rosen RF, Cintron A, Walker LC.

Curr Pharm Des. 2012;18(8):1159-69. Review.

2.

Comparative pathobiology of β-amyloid and the unique susceptibility of humans to Alzheimer's disease.

Rosen RF, Tomidokoro Y, Farberg AS, Dooyema J, Ciliax B, Preuss TM, Neubert TA, Ghiso JA, LeVine H 3rd, Walker LC.

Neurobiol Aging. 2016 Aug;44:185-196. doi: 10.1016/j.neurobiolaging.2016.04.019. Epub 2016 May 2.

3.

The Exceptional Vulnerability of Humans to Alzheimer's Disease.

Walker LC, Jucker M.

Trends Mol Med. 2017 Jun;23(6):534-545. doi: 10.1016/j.molmed.2017.04.001. Epub 2017 May 5. Review.

PMID:
28483344
4.

Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer's disease?

Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, Yamaguchi H, Westmoreland SV, Mansfield KG.

Rejuvenation Res. 2008 Apr;11(2):321-32. doi: 10.1089/rej.2008.0677.

PMID:
18341428
5.

PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease.

Rosen RF, Walker LC, Levine H 3rd.

Neurobiol Aging. 2011 Feb;32(2):223-34. doi: 10.1016/j.neurobiolaging.2009.02.011. Epub 2009 Mar 28.

6.

[Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (I)].

Toledano A, Alvarez MI, López-Rodríguez AB, Toledano-Díaz A, Fernández-Verdecia CI.

Neurologia. 2012 Jul-Aug;27(6):354-69. doi: 10.1016/j.nrl.2011.05.008. Epub 2011 Dec 24. Review. Spanish.

7.

Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.

Bates K, Vink R, Martins R, Harvey A.

Neurobiol Aging. 2014 Jun;35(6):1345-51. doi: 10.1016/j.neurobiolaging.2013.11.020. Epub 2013 Nov 27.

PMID:
24360504
8.

Age-associated changes of cerebrospinal fluid amyloid-β and tau in cynomolgus monkeys.

Yue F, Lu C, Ai Y, Chan P, Zhang Z.

Neurobiol Aging. 2014 Jul;35(7):1656-9. doi: 10.1016/j.neurobiolaging.2014.01.139. Epub 2014 Jan 31.

PMID:
24581480
9.

Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.

Isopi E, Granzotto A, Corona C, Bomba M, Ciavardelli D, Curcio M, Canzoniero LM, Navarra R, Lattanzio R, Piantelli M, Sensi SL.

Neurobiol Dis. 2015 Sep;81:214-24. doi: 10.1016/j.nbd.2014.11.013. Epub 2014 Nov 28.

PMID:
25434488
10.

Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.

Forny-Germano L, Lyra e Silva NM, Batista AF, Brito-Moreira J, Gralle M, Boehnke SE, Coe BC, Lablans A, Marques SA, Martinez AM, Klein WL, Houzel JC, Ferreira ST, Munoz DP, De Felice FG.

J Neurosci. 2014 Oct 8;34(41):13629-43. doi: 10.1523/JNEUROSCI.1353-14.2014.

11.

Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.

Ndung'u M, Härtig W, Wegner F, Mwenda JM, Low RW, Akinyemi RO, Kalaria RN.

Neuropathol Appl Neurobiol. 2012 Aug;38(5):487-99. doi: 10.1111/j.1365-2990.2011.01246.x.

PMID:
22126319
12.

Animal models of cerebral beta-amyloid angiopathy.

Walker LC.

Brain Res Brain Res Rev. 1997 Sep 30;25(1):70-84. Review.

PMID:
9370051
13.

The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.

Cheng XR, Zhou WX, Zhang YX.

Ageing Res Rev. 2014 Jan;13:13-37. doi: 10.1016/j.arr.2013.10.002. Epub 2013 Nov 21.

PMID:
24269312
14.

Amyloid-β and tau pathology of Alzheimer's disease induced by diabetes in a rabbit animal model.

Bitel CL, Kasinathan C, Kaswala RH, Klein WL, Frederikse PH.

J Alzheimers Dis. 2012;32(2):291-305. doi: 10.3233/JAD-2012-120571.

PMID:
22785400
15.
16.

Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.

Gontier G, George C, Chaker Z, Holzenberger M, Aïd S.

J Neurosci. 2015 Aug 19;35(33):11500-13. doi: 10.1523/JNEUROSCI.0343-15.2015.

17.

A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Hurtado DE, Molina-Porcel L, Iba M, Aboagye AK, Paul SM, Trojanowski JQ, Lee VM.

Am J Pathol. 2010 Oct;177(4):1977-88. doi: 10.2353/ajpath.2010.100346. Epub 2010 Aug 27.

18.

[Alzheimer disease: cellular and molecular aspects].

Octave JN.

Bull Mem Acad R Med Belg. 2005;160(10-12):445-9; discussion 450-1. French.

PMID:
16768248
19.

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.

Castillo-Carranza DL, Guerrero-Muñoz MJ, Sengupta U, Hernandez C, Barrett AD, Dineley K, Kayed R.

J Neurosci. 2015 Mar 25;35(12):4857-68. doi: 10.1523/JNEUROSCI.4989-14.2015.

20.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010

Supplemental Content

Support Center